Dr. Babak Givi, MD

Dr. Givi practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Givi's NPI, 1689883449, was assigned on May 21, 2007. Dr. Givi graduated from Tehran University of Medical Sciences School of Medicine in 1998. Dr. Givi holds New York license 249646.

Dr. Givi's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Givi's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Givi to 4 more medical groups, 3 group practices and clinics and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Givi practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Givi's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Givi is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Givi's licenses on file in 3 states: New York, Oregon and New Jersey.

Dmand AI lists larynx and vocal cord disease and thyroid surgery among the conditions Dr. Givi treats.

CMS data shows 406 Medicare services from Dr. Givi across 7 procedure codes in 2024, for 212 Medicare patients. Medicare paid $48,669 for them.

CMS counts 212 Medicare patients who saw Dr. Givi in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Givi's median patient age at 70, with 45% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Givi for performance year 2024, reported as part of a group. Dr. Givi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Givi as offering telehealth. CMS counts 21 procedures of melanoma (skin cancer) excision by Dr. Givi, more than 75% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 107 papers to Dr. Givi, published from 2010 to 2025. 2020 was the busiest year, with 18. The most frequent topics are Carcinoma, Squamous Cell, Head and Neck Neoplasms and Radiotherapy, Adjuvant. Dr. Givi has published most often in Head Neck. Dr. Givi's most frequent co-authors are Kenneth S. Hu, MD, Moses Min-Chi Tam and Luc Gt Morris, MD.

Dmand AI links Dr. Givi to 1 clinical trial. Conditions studied include Mouth Neoplasms and Mouth Diseases.

CMS Open Payments shows 11 general payments to Dr. Givi from 7 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Intersect ENT, Inc. paid the most, $145.

Dmand AI lists 3 awards for Dr. Givi, most recently Star Reviewer in 2015. Dr. Givi serves on AHNS Education Division.

Dr. Givi graduated from Tehran University of Medical Sciences School of Medicine in 1998. Dr. Givi is a member of NHS, American Association of Endocrine Surgeons, ACS and American Head & Neck Society.

Dr. Givi is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.